1q24 › Citations

Mutants of protein kinase A that mimic the ATP-binding site of protein kinase B (AKT).

Gassel M, Breitenlechner CB, Rüger P, Jucknischke U, Schneider T, Huber R, Bossemeyer D, Engh RA
J Mol Biol 329 1021-34 (2003)
Related entries: 1cdk, 1q61, 1q62

Cited: 100 times
EuropePMC logo PMID: 12798691

Abstract

The mutation of well behaved enzymes in order to simulate less manageable cognates is the obvious approach to study specific features of the recalcitrant target. Accordingly, the prototypical protein kinase PKA serves as a model for many kinases, including the closely related PKB, an AGC family protein kinase now implicated as oncogenic in several cancers. Two residues that differ between the alpha isoforms of PKA and PKB at the adenine-binding site generate differing shapes of the binding surface and are likely to play a role in ligand selectivity. As the corresponding mutations in PKA, V123A would enlarge the adenine pocket, while L173M would alter both the shape and its electronic character of the adenine-binding surface. We have determined the structures of the corresponding double mutant (PKAB2: PKAalpha V123A, L173M) in apo and MgATP-bound states, and observed structural alterations of a residue not previously involved in ATP-binding interactions: the side-chain of Q181, which in native PKA points away from the ATP-binding site, adopts in apo double mutant protein a new rotamer conformation, which places the polar groups at the hinge region in the ATP pocket. MgATP binding forces Q181 back to the position seen in native PKA. The crystal structure shows that ATP binding geometry is identical with that in native PKA but in this case was determined under conditions with only a single Mg ion ligand. Surface plasmon resonance spectroscopy studies show that significant energy is required for this ligand-induced transition. An additional PKA/PKB mutation, Q181K, corrects the defect, as shown both by the crystal structure of triple mutant PKAB3 (PKAalpha V123A, L173M, Q181K) and by surface plasmon resonance spectroscopy binding studies with ATP and three isoquinoline inhibitors. Thus, the triple mutant serves well as an easily crystallizable model for PKB inhibitor interactions. Further, the phenomenon of Q181 shows how crystallographic analysis should accompany mutant studies to monitor possible spurious structural effects.

Reviews - 1q24 mentioned but not cited (19)

  1. The human flavoproteome. Lienhart WD, Gudipati V, Macheroux P. Arch Biochem Biophys 535 150-162 (2013)
  2. The role of neuronal complexes in human X-linked brain diseases. Laumonnier F, Cuthbert PC, Grant SG. Am J Hum Genet 80 205-220 (2007)
  3. Detection of Tumor NTRK Gene Fusions to Identify Patients Who May Benefit from Tyrosine Kinase (TRK) Inhibitor Therapy. Hsiao SJ, Zehir A, Sireci AN, Aisner DL. J Mol Diagn 21 553-571 (2019)
  4. Role of genetics in the diagnosis and prognosis of Crohn's disease. Tsianos EV, Katsanos KH, Tsianos VE. World J Gastroenterol 18 105-118 (2012)
  5. Genetics of primary open angle glaucoma. Takamoto M, Araie M. Jpn J Ophthalmol 58 1-15 (2014)
  6. Human endogenous retrovirus group E and its involvement in diseases. Le Dantec C, Vallet S, Brooks WH, Renaudineau Y. Viruses 7 1238-1257 (2015)
  7. Rat models of human diseases and related phenotypes: a systematic inventory of the causative genes. Szpirer C. J Biomed Sci 27 84 (2020)
  8. Mechanistic insights and potential therapeutic approaches for NUP98-rearranged hematologic malignancies. Michmerhuizen NL, Klco JM, Mullighan CG. Blood 136 2275-2289 (2020)
  9. Biology and Management of Dedifferentiated Liposarcoma: State of the Art and Perspectives. Nishio J, Nakayama S, Nabeshima K, Yamamoto T. J Clin Med 10 3230 (2021)
  10. Role of genetics in the diagnosis and prognosis of Crohn's disease. Tsianos EV, Katsanos KH, Tsianos VE. World J Gastroenterol 17 5246-5259 (2011)
  11. The genetic landscape of the FAS pathway deficiencies. Magerus A, Bercher-Brayer C, Rieux-Laucat F. Biomed J 44 388-399 (2021)
  12. Currently recognized clinically relevant and known genes for human reproduction and related infertility with representation on high-resolution chromosome ideograms. Butler MG, Rafi SK, McGuire A, Manzardo AM. Gene 575 149-159 (2016)
  13. Updates on Genes and Genetic Mechanisms Implicated in Primary Angle-Closure Glaucoma. Kondkar AA. Appl Clin Genet 14 89-112 (2021)
  14. Expression and functions of adenylyl cyclases in the CNS. Devasani K, Yao Y. Fluids Barriers CNS 19 23 (2022)
  15. Shared (epi)genomic background connecting neurodegenerative diseases and type 2 diabetes. Caputo V, Termine A, Strafella C, Giardina E, Cascella R. World J Diabetes 11 155-164 (2020)
  16. Developmental Cues and Molecular Drivers in Myelinogenesis: Revisiting Early Life to Re-Evaluate the Integrity of CNS Myelin. Dermitzakis I, Manthou ME, Meditskou S, Miliaras D, Kesidou E, Boziki M, Petratos S, Grigoriadis N, Theotokis P. Curr Issues Mol Biol 44 3208-3237 (2022)
  17. Precision Medicine in Glaucoma: Artificial Intelligence, Biomarkers, Genetics and Redox State. Fea AM, Ricardi F, Novarese C, Cimorosi F, Vallino V, Boscia G. Int J Mol Sci 24 2814 (2023)
  18. Pregnancy-Associated Plasma Protein (PAPP)-A2 in Physiology and Disease. Barrios V, Chowen JA, Martín-Rivada Á, Guerra-Cantera S, Pozo J, Yakar S, Rosenfeld RG, Pérez-Jurado LA, Suárez J, Argente J. Cells 10 3576 (2021)
  19. The genetics of glaucoma: Disease associations, personalised risk assessment and therapeutic opportunities-A review. Aboobakar IF, Wiggs JL. Clin Exp Ophthalmol 50 143-162 (2022)

Articles - 1q24 mentioned but not cited (56)

  1. Identification and characterization of novel human endogenous retrovirus families by phylogenetic screening of the human genome mapping project database. Tristem M. J Virol 74 3715-3730 (2000)
  2. The AAA+ protein torsinA interacts with a conserved domain present in LAP1 and a novel ER protein. Goodchild RE, Dauer WT. J Cell Biol 168 855-862 (2005)
  3. Common genetic determinants of intraocular pressure and primary open-angle glaucoma. van Koolwijk LM, Ramdas WD, Ikram MK, Jansonius NM, Pasutto F, Hysi PG, Macgregor S, Janssen SF, Hewitt AW, Viswanathan AC, ten Brink JB, Hosseini SM, Amin N, Despriet DD, Willemse-Assink JJ, Kramer R, Rivadeneira F, Struchalin M, Aulchenko YS, Weisschuh N, Zenkel M, Mardin CY, Gramer E, Welge-Lüssen U, Montgomery GW, Carbonaro F, Young TL, DCCT/EDIC Research Group, Bellenguez C, McGuffin P, Foster PJ, Topouzis F, Mitchell P, Wang JJ, Wong TY, Czudowska MA, Hofman A, Uitterlinden AG, Wolfs RC, de Jong PT, Oostra BA, Paterson AD, Wellcome Trust Case Control Consortium 2, Mackey DA, Bergen AA, Reis A, Hammond CJ, Vingerling JR, Lemij HG, Klaver CC, van Duijn CM. PLoS Genet 8 e1002611 (2012)
  4. Molecular phylogeny of the kelch-repeat superfamily reveals an expansion of BTB/kelch proteins in animals. Prag S, Adams JC. BMC Bioinformatics 4 42 (2003)
  5. Chromatin immunoprecipitation microarrays for identification of genes silenced by histone H3 lysine 9 methylation. Kondo Y, Shen L, Yan PS, Huang TH, Issa JP. Proc Natl Acad Sci U S A 101 7398-7403 (2004)
  6. Illuminating radiogenomic characteristics of glioblastoma multiforme through integration of MR imaging, messenger RNA expression, and DNA copy number variation. Jamshidi N, Diehn M, Bredel M, Kuo MD. Radiology 270 1-2 (2014)
  7. Lobular and ductal carcinomas of the breast have distinct genomic and expression profiles. Bertucci F, Orsetti B, Nègre V, Finetti P, Rougé C, Ahomadegbe JC, Bibeau F, Mathieu MC, Treilleux I, Jacquemier J, Ursule L, Martinec A, Wang Q, Bénard J, Puisieux A, Birnbaum D, Theillet C. Oncogene 27 5359-5372 (2008)
  8. Regulation of UHRF1 by dual-strand tumor-suppressor microRNA-145 (miR-145-5p and miR-145-3p): Inhibition of bladder cancer cell aggressiveness. Matsushita R, Yoshino H, Enokida H, Goto Y, Miyamoto K, Yonemori M, Inoguchi S, Nakagawa M, Seki N. Oncotarget 7 28460-28487 (2016)
  9. Analysis of the RNASEL gene in familial and sporadic prostate cancer. Wang L, McDonnell SK, Elkins DA, Slager SL, Christensen E, Marks AF, Cunningham JM, Peterson BJ, Jacobsen SJ, Cerhan JR, Blute ML, Schaid DJ, Thibodeau SN. Am J Hum Genet 71 116-123 (2002)
  10. Mutations in pregnancy-associated plasma protein A2 cause short stature due to low IGF-I availability. Dauber A, Muñoz-Calvo MT, Barrios V, Domené HM, Kloverpris S, Serra-Juhé C, Desikan V, Pozo J, Muzumdar R, Martos-Moreno GÁ, Hawkins F, Jasper HG, Conover CA, Frystyk J, Yakar S, Hwa V, Chowen JA, Oxvig C, Rosenfeld RG, Pérez-Jurado LA, Argente J. EMBO Mol Med 8 363-374 (2016)
  11. A distinct molecular profile associated with mucinous epithelial ovarian cancer. Heinzelmann-Schwarz VA, Gardiner-Garden M, Henshall SM, Scurry JP, Scolyer RA, Smith AN, Bali A, Vanden Bergh P, Baron-Hay S, Scott C, Fink D, Hacker NF, Sutherland RL, O'Brien PM. Br J Cancer 94 904-913 (2006)
  12. Rhabdoid tumor: gene expression clues to pathogenesis and potential therapeutic targets. Gadd S, Sredni ST, Huang CC, Perlman EJ, Renal Tumor Committee of the Children's Oncology Group. Lab Invest 90 724-738 (2010)
  13. Genetic profiling of chromosome 1 in breast cancer: mapping of regions of gains and losses and identification of candidate genes on 1q. Orsetti B, Nugoli M, Cervera N, Lasorsa L, Chuchana P, Rougé C, Ursule L, Nguyen C, Bibeau F, Rodriguez C, Theillet C. Br J Cancer 95 1439-1447 (2006)
  14. Molecular profile of peripheral blood mononuclear cells from patients with rheumatoid arthritis. Edwards CJ, Feldman JL, Beech J, Shields KM, Stover JA, Trepicchio WL, Larsen G, Foxwell BM, Brennan FM, Feldmann M, Pittman DD. Mol Med 13 40-58 (2007)
  15. The repertoire of Na,K-ATPase alpha and beta subunit genes expressed in the zebrafish, Danio rerio. Rajarao SJ, Canfield VA, Mohideen MA, Yan YL, Postlethwait JH, Cheng KC, Levenson R. Genome Res 11 1211-1220 (2001)
  16. MYCN-non-amplified metastatic neuroblastoma with good prognosis and spontaneous regression: a molecular portrait of stage 4S. Bénard J, Raguénez G, Kauffmann A, Valent A, Ripoche H, Joulin V, Job B, Danglot G, Cantais S, Robert T, Terrier-Lacombe MJ, Chassevent A, Koscielny S, Fischer M, Berthold F, Lipinski M, Tursz T, Dessen P, Lazar V, Valteau-Couanet D. Mol Oncol 2 261-271 (2008)
  17. Genomic organization and evolution of double minutes/homogeneously staining regions with MYC amplification in human cancer. L'Abbate A, Macchia G, D'Addabbo P, Lonoce A, Tolomeo D, Trombetta D, Kok K, Bartenhagen C, Whelan CW, Palumbo O, Severgnini M, Cifola I, Dugas M, Carella M, De Bellis G, Rocchi M, Carbone L, Storlazzi CT. Nucleic Acids Res 42 9131-9145 (2014)
  18. Associations of Mitochondrial and Nuclear Mitochondrial Variants and Genes with Seven Metabolic Traits. Kraja AT, Liu C, Fetterman JL, Graff M, Have CT, Gu C, Yanek LR, Feitosa MF, Arking DE, Chasman DI, Young K, Ligthart S, Hill WD, Weiss S, Luan J, Giulianini F, Li-Gao R, Hartwig FP, Lin SJ, Wang L, Richardson TG, Yao J, Fernandez EP, Ghanbari M, Wojczynski MK, Lee WJ, Argos M, Armasu SM, Barve RA, Ryan KA, An P, Baranski TJ, Bielinski SJ, Bowden DW, Broeckel U, Christensen K, Chu AY, Corley J, Cox SR, Uitterlinden AG, Rivadeneira F, Cropp CD, Daw EW, van Heemst D, de Las Fuentes L, Gao H, Tzoulaki I, Ahluwalia TS, de Mutsert R, Emery LS, Erzurumluoglu AM, Perry JA, Fu M, Forouhi NG, Gu Z, Hai Y, Harris SE, Hemani G, Hunt SC, Irvin MR, Jonsson AE, Justice AE, Kerrison ND, Larson NB, Lin KH, Love-Gregory LD, Mathias RA, Lee JH, Nauck M, Noordam R, Ong KK, Pankow J, Patki A, Pattie A, Petersmann A, Qi Q, Ribel-Madsen R, Rohde R, Sandow K, Schnurr TM, Sofer T, Starr JM, Taylor AM, Teumer A, Timpson NJ, de Haan HG, Wang Y, Weeke PE, Williams C, Wu H, Yang W, Zeng D, Witte DR, Weir BS, Wareham NJ, Vestergaard H, Turner ST, Torp-Pedersen C, Stergiakouli E, Sheu WH, Rosendaal FR, Ikram MA, Franco OH, Ridker PM, Perls TT, Pedersen O, Nohr EA, Newman AB, Linneberg A, Langenberg C, Kilpeläinen TO, Kardia SLR, Jørgensen ME, Jørgensen T, Sørensen TIA, Homuth G, Hansen T, Goodarzi MO, Deary IJ, Christensen C, Chen YI, Chakravarti A, Brandslund I, Bonnelykke K, Taylor KD, Wilson JG, Rodriguez S, Davies G, Horta BL, Thyagarajan B, Rao DC, Grarup N, Davila-Roman VG, Hudson G, Guo X, Arnett DK, Hayward C, Vaidya D, Mook-Kanamori DO, Tiwari HK, Levy D, Loos RJF, Dehghan A, Elliott P, Malik AN, Scott RA, Becker DM, de Andrade M, Province MA, Meigs JB, Rotter JI, North KE. Am J Hum Genet 104 112-138 (2019)
  19. Genome-wide gene-environment interaction analysis for asbestos exposure in lung cancer susceptibility. Wei S, Wang LE, McHugh MK, Han Y, Xiong M, Amos CI, Spitz MR, Wei QW. Carcinogenesis 33 1531-1537 (2012)
  20. Retinal cell responses to elevated intraocular pressure: a gene array comparison between the whole retina and retinal ganglion cell layer. Guo Y, Cepurna WO, Dyck JA, Doser TA, Johnson EC, Morrison JC. Invest Ophthalmol Vis Sci 51 3003-3018 (2010)
  21. Effects of pulsed electromagnetic fields on human osteoblastlike cells (MG-63): a pilot study. Sollazzo V, Palmieri A, Pezzetti F, Massari L, Carinci F. Clin Orthop Relat Res 468 2260-2277 (2010)
  22. Identifying in-trans process associated genes in breast cancer by integrated analysis of copy number and expression data. Aure MR, Steinfeld I, Baumbusch LO, Liestøl K, Lipson D, Nyberg S, Naume B, Sahlberg KK, Kristensen VN, Børresen-Dale AL, Lingjærde OC, Yakhini Z. PLoS One 8 e53014 (2013)
  23. Investigation of chromosome 1q reveals differential expression of members of the S100 family in clinical subgroups of intracranial paediatric ependymoma. Rand V, Prebble E, Ridley L, Howard M, Wei W, Brundler MA, Fee BE, Riggins GJ, Coyle B, Grundy RG, Children's Cancer and Leukaemia Group Biological Studies Committee. Br J Cancer 99 1136-1143 (2008)
  24. Clinical whole genome sequencing as a first-tier test at a resource-limited dysmorphology clinic in Mexico. Scocchia A, Wigby KM, Masser-Frye D, Del Campo M, Galarreta CI, Thorpe E, McEachern J, Robinson K, Gross A, ICSL Interpretation and Reporting Team, Ajay SS, Rajan V, Perry DL, Belmont JW, Bentley DR, Jones MC, Taft RJ. NPJ Genom Med 4 5 (2019)
  25. Comparative gene-expression analysis of the dental follicle and periodontal ligament in humans. Lee HS, Lee J, Kim SO, Song JS, Lee JH, Lee SI, Jung HS, Choi BJ. PLoS One 8 e84201 (2013)
  26. Microarray analysis of mercury-induced changes in gene expression in human liver carcinoma (HepG2) cells: importance in immune responses. Ayensu WK, Tchounwou PB. Int J Environ Res Public Health 3 141-173 (2006)
  27. ZNF-mediated resistance to imatinib mesylate in gastrointestinal stromal tumor. Rink L, Ochs MF, Zhou Y, von Mehren M, Godwin AK. PLoS One 8 e54477 (2013)
  28. High-resolution chromosome ideogram representation of recognized genes for bipolar disorder. Douglas LN, McGuire AB, Manzardo AM, Butler MG. Gene 586 136-147 (2016)
  29. Impact on disease development, genomic location and biological function of copy number alterations in non-small cell lung cancer. Huang YT, Lin X, Chirieac LR, McGovern R, Wain JC, Heist RS, Skaug V, Zienolddiny S, Haugen A, Su L, Christiani DC. PLoS One 6 e22961 (2011)
  30. Consistent across-tissue signatures of differential gene expression in Crohn's disease. Hughes AL. Immunogenetics 57 709-716 (2005)
  31. Currently recognized genes for schizophrenia: High-resolution chromosome ideogram representation. Butler MG, McGuire AB, Masoud H, Manzardo AM. Am J Med Genet B Neuropsychiatr Genet 171B 181-202 (2016)
  32. Novel Gene Expression Signature Predictive of Clinical Recurrence After Radical Prostatectomy in Early Stage Prostate Cancer Patients. Shahabi A, Lewinger JP, Ren J, April C, Sherrod AE, Hacia JG, Daneshmand S, Gill I, Pinski JK, Fan JB, Stern MC. Prostate 76 1239-1256 (2016)
  33. Gene expression in TGFbeta-induced epithelial cell differentiation in a three-dimensional intestinal epithelial cell differentiation model. Juuti-Uusitalo KM, Kaukinen K, Mäki M, Tuimala J, Kainulainen H. BMC Genomics 7 279 (2006)
  34. Integrative molecular characterization of head and neck cancer cell model genomes. Tsui IF, Garnis C. Head Neck 32 1143-1160 (2010)
  35. Computational analysis of multimorbidity between asthma, eczema and rhinitis. Aguilar D, Pinart M, Koppelman GH, Saeys Y, Nawijn MC, Postma DS, Akdis M, Auffray C, Ballereau S, Benet M, García-Aymerich J, González JR, Guerra S, Keil T, Kogevinas M, Lambrecht B, Lemonnier N, Melen E, Sunyer J, Valenta R, Valverde S, Wickman M, Bousquet J, Oliva B, Antó JM. PLoS One 12 e0179125 (2017)
  36. POU2F1 promotes growth and metastasis of hepatocellular carcinoma through the FAT1 signaling pathway. Zhu HY, Cao GY, Wang SP, Chen Y, Liu GD, Gao YJ, Hu JP. Am J Cancer Res 7 1665-1679 (2017)
  37. Polymorphism rs7555523 in transmembrane and coiled-coil domain 1 (TMCO1) is not a risk factor for primary open angle glaucoma in a Saudi cohort. Kondkar AA, Mousa A, Azad TA, Sultan T, Alawad A, Altuwaijri S, Al-Obeidan SA, Abu-Amero KK. J Negat Results Biomed 15 17 (2016)
  38. Identification of Achaete-scute complex-like 1 (ASCL1) target genes and evaluation of DKK1 and TPH1 expression in pancreatic endocrine tumours. Johansson TA, Westin G, Skogseid B. BMC Cancer 9 321 (2009)
  39. Genetic Discoveries in Atrial Fibrillation and Implications for Clinical Practice. Mahida S. Arrhythm Electrophysiol Rev 3 69-75 (2014)
  40. Screening and identification of differentially expressed transcripts in circulating cells of prostate cancer patients using suppression subtractive hybridization. Li X, Wong C, Mysel R, Slobodov G, Metwalli A, Kruska J, Manatt CS, Culkin DJ, Kropp BP, Lin HK. Mol Cancer 4 30 (2005)
  41. Ocular expression and distribution of products of the POAG-associated chromosome 9p21 gene region. Chidlow G, Wood JP, Sharma S, Dimasi DP, Burdon KP, Casson RJ, Craig JE. PLoS One 8 e75067 (2013)
  42. Evolutionary history of the human multigene families reveals widespread gene duplications throughout the history of animals. Pervaiz N, Shakeel N, Qasim A, Zehra R, Anwar S, Rana N, Xue Y, Zhang Z, Bao Y, Abbasi AA. BMC Evol Biol 19 128 (2019)
  43. Genome-wide enriched pathway analysis of acute post-radiotherapy pain in breast cancer patients: a prospective cohort study. Lee E, Takita C, Wright JL, Slifer SH, Martin ER, Urbanic JJ, Langefeld CD, Lesser GJ, Shaw EG, Hu JJ. Hum Genomics 13 28 (2019)
  44. Global, pathway and gene coverage of three Illumina arrays with respect to inflammatory and immune-related pathways. Tozzi V, Rosenberger A, Kube D, Bickeböller H. Eur J Hum Genet 27 1716-1723 (2019)
  45. Identification of a glioma functional network from gene fitness data using machine learning. Xiang CX, Liu XG, Zhou DQ, Zhou Y, Wang X, Chen F. J Cell Mol Med 26 1253-1263 (2022)
  46. MACE-Seq-based coding RNA and TrueQuant-based small RNA profile in breast cancer: tumor-suppressive miRNA-1275 identified as a novel marker. Majed SO, Mustafa SA. BMC Cancer 21 473 (2021)
  47. Bioinformatic analysis of gene expression data reveals Src family protein tyrosine kinases as key players in androgenetic alopecia. Premanand A, Reena Rajkumari B. Front Med (Lausanne) 10 1108358 (2023)
  48. Congenital factor V deficiency from compound heterozygous mutations with a novel variant c.2426del (p.Pro809Hisfs*2) in the F5 gene: A case report. Park CH, Park MS, Lee KO, Kim SH, Park YS, Kim HJ. Medicine (Baltimore) 99 e18947 (2020)
  49. Dataset of GWAS-identified variants underlying venous thromboembolism susceptibility and linkage to cancer aggressiveness. Tavares V, Pinto R, Assis J, Pereira D, Medeiros R. Data Brief 30 105399 (2020)
  50. Case Reports Genetic Predictors of the Development of Complications after Coronary Stenting. Taizhanova D, Kalimbetova A, Bodaubay R, Toleuova A, Toiynbekova R, Beysenbekova Z, Visternichan O, Tauesheva Z, Kadyrova I, Babenko D, Akhmaltdinova L, Kolesnichenko S, Kolesnikova Y, Avdienko OV, Akilzhanova A, Gerotziafas GT. J Pers Med 13 14 (2022)
  51. Identification of the Key Regulators of Spina Bifida Through Graph-Theoretical Approach. Tamkeen N, AlOmar SY, Alqahtani SAM, Al-Jurayyan A, Farooqui A, Tazyeen S, Ahmad N, Ishrat R. Front Genet 12 597983 (2021)
  52. Identified Isosteric Replacements of Ligands' Glycosyl Domain by Data Mining. Zhang T, Jiang S, Li T, Liu Y, Zhang Y. ACS Omega 8 25165-25184 (2023)
  53. Mapping the 3D structures of small molecule binding sites Meyers J, Brown N, Blagg J. J Cheminform 8 (2016)
  54. SCYL3, as a novel binding partner and regulator of ROCK2, promotes hepatocellular carcinoma progression. Lei MML, Leung CON, Lau EYT, Leung RWH, Ma VWS, Tong M, Lu YY, Huang CY, Zhu QH, Ng IOL, Ma S, Lee TKW. JHEP Rep 5 100604 (2023)
  55. The profiles of miR-4510 expression level in breast cancer. Majed SO, Mustafa SA. Sci Rep 13 2262 (2023)
  56. Tumor Androgen Receptor Protein Level Is Positively Associated with a Better Overall Survival in Melanoma Patients. Singh N, Khatib J, Chiu CY, Lin J, Patel TS, Liu-Smith F. Genes (Basel) 14 345 (2023)


Reviews citing this publication (6)

  1. Aromatic rings in chemical and biological recognition: energetics and structures. Salonen LM, Ellermann M, Diederich F. Angew Chem Int Ed Engl 50 4808-4842 (2011)
  2. Drug discovery approaches targeting the PI3K/Akt pathway in cancer. Garcia-Echeverria C, Sellers WR. Oncogene 27 5511-5526 (2008)
  3. Survey of the year 2003 commercial optical biosensor literature. Rich RL, Myszka DG. J Mol Recognit 18 1-39 (2005)
  4. Structure-based design of molecular cancer therapeutics. van Montfort RL, Workman P. Trends Biotechnol 27 315-328 (2009)
  5. The chemical diversity and structure-based discovery of allosteric modulators for the PIF-pocket of protein kinase PDK1. Xu X, Chen Y, Fu Q, Ni D, Zhang J, Li X, Lu S. J Enzyme Inhib Med Chem 34 361-374 (2019)
  6. Computer-Aided Identification of Kinase-Targeted Small Molecules for Cancer: A Review on AKT Protein. Primavera E, Palazzotti D, Barreca ML, Astolfi A. Pharmaceuticals (Basel) 16 993 (2023)

Articles citing this publication (19)

  1. Protein kinase A in complex with Rho-kinase inhibitors Y-27632, Fasudil, and H-1152P: structural basis of selectivity. Breitenlechner C, Gassel M, Hidaka H, Kinzel V, Huber R, Engh RA, Bossemeyer D. Structure 11 1595-1607 (2003)
  2. Structure and functional characterization of the atypical human kinase haspin. Eswaran J, Patnaik D, Filippakopoulos P, Wang F, Stein RL, Murray JW, Higgins JM, Knapp S. Proc Natl Acad Sci U S A 106 20198-20203 (2009)
  3. A structural comparison of inhibitor binding to PKB, PKA and PKA-PKB chimera. Davies TG, Verdonk ML, Graham B, Saalau-Bethell S, Hamlett CC, McHardy T, Collins I, Garrett MD, Workman P, Woodhead SJ, Jhoti H, Barford D. J Mol Biol 367 882-894 (2007)
  4. Design and synthesis of Rho kinase inhibitors (I). Takami A, Iwakubo M, Okada Y, Kawata T, Odai H, Takahashi N, Shindo K, Kimura K, Tagami Y, Miyake M, Fukushima K, Inagaki M, Amano M, Kaibuchi K, Iijima H. Bioorg Med Chem 12 2115-2137 (2004)
  5. NMR backbone assignment of a protein kinase catalytic domain by a combination of several approaches: application to the catalytic subunit of cAMP-dependent protein kinase. Langer T, Vogtherr M, Elshorst B, Betz M, Schieborr U, Saxena K, Schwalbe H. Chembiochem 5 1508-1516 (2004)
  6. The protein kinase C inhibitor bisindolyl maleimide 2 binds with reversed orientations to different conformations of protein kinase A. Gassel M, Breitenlechner CB, König N, Huber R, Engh RA, Bossemeyer D. J Biol Chem 279 23679-23690 (2004)
  7. Structural analysis of protein kinase A mutants with Rho-kinase inhibitor specificity. Bonn S, Herrero S, Breitenlechner CB, Erlbruch A, Lehmann W, Engh RA, Gassel M, Bossemeyer D. J Biol Chem 281 24818-24830 (2006)
  8. Structure-based design of isoquinoline-5-sulfonamide inhibitors of protein kinase B. Collins I, Caldwell J, Fonseca T, Donald A, Bavetsias V, Hunter LJ, Garrett MD, Rowlands MG, Aherne GW, Davies TG, Berdini V, Woodhead SJ, Davis D, Seavers LC, Wyatt PG, Workman P, McDonald E. Bioorg Med Chem 14 1255-1273 (2006)
  9. Diversity of bisubstrate binding modes of adenosine analogue-oligoarginine conjugates in protein kinase a and implications for protein substrate interactions. Pflug A, Rogozina J, Lavogina D, Enkvist E, Uri A, Engh RA, Bossemeyer D. J Mol Biol 403 66-77 (2010)
  10. The discovery of potent ribosomal S6 kinase inhibitors by high-throughput screening and structure-guided drug design. Couty S, Westwood IM, Kalusa A, Cano C, Travers J, Boxall K, Chow CL, Burns S, Schmitt J, Pickard L, Barillari C, McAndrew PC, Clarke PA, Linardopoulos S, Griffin RJ, Aherne GW, Raynaud FI, Workman P, Jones K, van Montfort RL. Oncotarget 4 1647-1661 (2013)
  11. 2-Aminothiadiazole inhibitors of AKT1 as potential cancer therapeutics. Zeng Q, Bourbeau MP, Wohlhieter GE, Yao G, Monenschein H, Rider JT, Lee MR, Zhang S, Lofgren J, Freeman D, Li C, Tominey E, Huang X, Hoffman D, Yamane H, Tasker AS, Dominguez C, Viswanadhan VN, Hungate R, Zhang X. Bioorg Med Chem Lett 20 1652-1656 (2010)
  12. Addressing the Glycine-Rich Loop of Protein Kinases by a Multi-Facetted Interaction Network: Inhibition of PKA and a PKB Mimic. Lauber BS, Hardegger LA, Alam KA, Lund BA, Dumele O, Harder M, Kuhn B, Engh RA, Diederich F. Chemistry 22 211-221 (2016)
  13. Elucidation of binding mode and three dimensional quantitative structure-activity relationship studies of a novel series of protein kinase B/Akt inhibitors. Muddassar M, Pasha FA, Neaz MM, Saleem Y, Cho SJ. J Mol Model 15 183-192 (2009)
  14. Folding and activity of cAMP-dependent protein kinase mutants. Langer T, Sreeramulu S, Vogtherr M, Elshorst B, Betz M, Schieborr U, Saxena K, Schwalbe H. FEBS Lett 579 4049-4054 (2005)
  15. Mutants of protein kinase A that mimic the ATP-binding site of Aurora kinase. Pflug A, de Oliveira TM, Bossemeyer D, Engh RA. Biochem J 440 85-93 (2011)
  16. Predicting structural and energetic changes in Met-aromatic motifs on methionine oxidation to the sulfoxide and sulfone. Orabi EA, English AM. Phys Chem Chem Phys 20 23132-23141 (2018)
  17. 2,3,5-Trisubstituted pyridines as selective AKT inhibitors-Part I: Substitution at 2-position of the core pyridine for ROCK1 selectivity. Lin H, Yamashita DS, Zeng J, Xie R, Wang W, Nidarmarthy S, Luengo JI, Rhodes N, Knick VB, Choudhry AE, Lai Z, Minthorn EA, Strum SL, Wood ER, Elkins PA, Concha NO, Heerding DA. Bioorg Med Chem Lett 20 673-678 (2010)
  18. Design and synthesis of novel amide AKT1 inhibitors with selectivity over CDK2. Ashton KS, St Jean DJ, Poon SF, Lee MR, Allen JG, Zhang S, Lofgren JA, Zhang X, Fotsch C, Hungate R. Bioorg Med Chem Lett 21 5191-5196 (2011)
  19. Rationally Designed PI3Kα Mutants to Mimic ATR and Their Use to Understand Binding Specificity of ATR Inhibitors. Lu Y, Knapp M, Crawford K, Warne R, Elling R, Yan K, Doyle M, Pardee G, Zhang L, Ma S, Mamo M, Ornelas E, Pan Y, Bussiere D, Jansen J, Zaror I, Lai A, Barsanti P, Sim J. J Mol Biol 429 1684-1704 (2017)


Related citations provided by authors (1)

  1. Phosphotransferase and substrate binding mechanism of the cAMP-dependent protein kinase catalytic subunit from porcine heart as deduced from the 2.0 A structure of the complex with Mn2+ adenylyl imidodiphosphate and inhibitor peptide PKI(5-24).. Bossemeyer D, Engh RA, Kinzel V, Ponstingl H, Huber R EMBO J 12 849-59 (1993)

Quick links